Topcu, S. Et Al. 2015. The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.21, no.8 , 783-789.

Topcu, S., Karal, H., Kaya, A., Bakirci, E. M., Tanboga, I. H., Kurt, M., ... Aksakal, E.(2015). The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.21, no.8, 783-789.

Topcu, Selim Et Al. "The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.21, no.8, 783-789, 2015

Topcu, Selim Et Al. "The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.21, no.8, pp.783-789, 2015

Topcu, S. Et Al. (2015) . "The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.21, no.8, pp.783-789.

@article{article, author={Selim TOPCU Et Al. }, title={The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2015, pages={783-789} }